search
Back to results

Heavy Weight Versus Medium Weight Mesh in Ventral Hernia Repair

Primary Purpose

Ventral Hernia

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Heavy weight Mesh
Medium weight Mesh
Sponsored by
The Cleveland Clinic
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Ventral Hernia focused on measuring Ventral Hernia Repair, Heavy weight Mesh, Medium weight Mesh

Eligibility Criteria

18 Years - 90 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • 18 years of age or older
  • Will undergo a single-stage, open, retromuscular ventral hernia repair
  • CDC Wound Class 1
  • Able to achieve midline fascial closure
  • Hernia defect width less than or equal to 20 centimeters (measured intraoperatively)
  • Able to tolerate general anesthesia
  • Able to give informed consent

Exclusion Criteria:

  • Patients who are less than 18 years of age
  • Patients who undergo emergent ventral hernia repair
  • Patients who undergo laparoscopic or robotic ventral hernia repair
  • Patients with CDC Wound Class 2, 3, or 4
  • Patients who are unable to undergo successful retromuscular mesh placement or who cannot achieve midline fascial closure
  • Patients who undergo staged repair of their ventral hernia
  • Patients who are unable to give informed consent
  • Patients who cannot tolerate general anesthesia
  • Patients who are pregnant at the time of surgical intervention

Sites / Locations

  • Cleveland Clinic Foundation

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Heavy weight Mesh

Medium weight Mesh

Arm Description

Intervention: Patients will undergo ventral hernia repair with implantation of a heavy weight mesh.

Intervention: Patients will undergo ventral hernia repair with implantation of a medium weight mesh.

Outcomes

Primary Outcome Measures

Pain Scores
Pain Scores will be measured using the NIH Promis 3A Pain Scale. PROMIS® Pain Intensity 3A is a three-question instrument developed to measure the range of pain experienced in the week prior to assessment. The raw score (3-15) is converted into a T-score where 50 (SD 10) represents the average of people with at least mild pain, higher numbers (maximum 71.8) represent higher than average pain, and the lowest score (30.7) represents no pain.

Secondary Outcome Measures

Number of Subjects With Hernia Recurrence
Hernia recurrence will be determined using the Ventral Hernia Recurrence Inventory.
Deep Wound Infection
The occurrence of a deep wound infection will be determine based on physical examination and/or computed tomography scanning.
Quality of Life Scores
Quality of life will be measured using the HerQLes quality of life questionnaire. HerQLes is a twelve-question instrument developed to evaluate quality of life and function as it pertains to the abdominal wall. It is converted into a 0-100 scale with 0 representing poor abdominal wall function, and 100 excellent function.

Full Information

First Posted
March 12, 2017
Last Updated
June 22, 2022
Sponsor
The Cleveland Clinic
search

1. Study Identification

Unique Protocol Identification Number
NCT03082391
Brief Title
Heavy Weight Versus Medium Weight Mesh in Ventral Hernia Repair
Official Title
Long-term Results of Heavy Weight Versus Medium Weight Mesh in Ventral Hernia Repair
Study Type
Interventional

2. Study Status

Record Verification Date
June 2022
Overall Recruitment Status
Completed
Study Start Date
March 14, 2017 (Actual)
Primary Completion Date
May 28, 2020 (Actual)
Study Completion Date
May 28, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Cleveland Clinic

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine if mesh weight has an impact on postoperative pain, ventral hernia recurrence, incidence of deep wound infection, and overall quality of life following ventral hernia repair with mesh.
Detailed Description
Approximately five million laparotomies are performed annually in the United States with upwards of 25% of these patients developing a ventral hernia postoperatively. Despite the prevalence of ventral hernias, the surgical approach to these procedures lacks standardization. In fact, nearly 20%-50% of patients undergoing ventral hernia repair (VHR) will experience a hernia recurrence. There are several factors that can contribute to ventral hernia recurrence. One of these is the use of prosthetic reinforcement. Although previous studies have shown that the use of mesh during VHR significantly decreases the risk of ventral hernia recurrence, guidelines for the ideal prosthetic material remain unknown. In terms of synthetic mesh, there are proponents that argue the value of medium weight material (40-60 g/m2) in order to combat the risk of postoperative deep surgical site infection and minimize the risk of a "stiff abdomen" or chronic pain syndromes.3-5 On the other hand, however, proponents of a heavier weight material ( > 80 g/m2) argue that its tensile strength leads to a long-term, durable hernia repair with decreased risk of hernia recurrence. To help determine if mesh weight has an impact on postoperative pain, we propose a registry based, randomized clinical trial (RCT) through the Americas Hernia Society Quality Collaborative (AHSQC). The AHSQC is a multicenter, nationwide quality improvement effort with a mission to improve value in hernia care.6 Data are collected prospectively in the routine care of hernia patients for quality improvement purposes. The information collected in the AHSQC offers a natural repository of information that can be used for research, in addition to its quality improvement purpose. The investigators hypothesize that patients who undergo ventral hernia repair with medium weight mesh will have significantly less pain than those patients who undergo ventral hernia repair using heavy weight mesh one year after operation. Both the intended randomization arms of the study are accepted standard of care practices in use by surgeons. Specific Aim #1: To determine if the use of a medium weight material leads to a decrease in pain intensity at one year following ventral hernia repair. Specific Aim #2: To determine if there is a difference in ventral hernia recurrence at one year following surgery. Specific Aim #3: To determine if there is a difference in the rate of deep surgical site infection at 30-days following surgery between the two mesh types. Specific Aim #4: To determine if there is a difference in the quality of life between the two groups at one year following surgery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ventral Hernia
Keywords
Ventral Hernia Repair, Heavy weight Mesh, Medium weight Mesh

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
350 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Heavy weight Mesh
Arm Type
Active Comparator
Arm Description
Intervention: Patients will undergo ventral hernia repair with implantation of a heavy weight mesh.
Arm Title
Medium weight Mesh
Arm Type
Active Comparator
Arm Description
Intervention: Patients will undergo ventral hernia repair with implantation of a medium weight mesh.
Intervention Type
Device
Intervention Name(s)
Heavy weight Mesh
Intervention Description
Patients will undergo ventral hernia repair with heavy weight mesh.
Intervention Type
Device
Intervention Name(s)
Medium weight Mesh
Intervention Description
Patients will undergo ventral hernia repair with medium weight mesh.
Primary Outcome Measure Information:
Title
Pain Scores
Description
Pain Scores will be measured using the NIH Promis 3A Pain Scale. PROMIS® Pain Intensity 3A is a three-question instrument developed to measure the range of pain experienced in the week prior to assessment. The raw score (3-15) is converted into a T-score where 50 (SD 10) represents the average of people with at least mild pain, higher numbers (maximum 71.8) represent higher than average pain, and the lowest score (30.7) represents no pain.
Time Frame
One Year Postoperatively
Secondary Outcome Measure Information:
Title
Number of Subjects With Hernia Recurrence
Description
Hernia recurrence will be determined using the Ventral Hernia Recurrence Inventory.
Time Frame
One Year Postoperatively
Title
Deep Wound Infection
Description
The occurrence of a deep wound infection will be determine based on physical examination and/or computed tomography scanning.
Time Frame
30-Days Postoperatively
Title
Quality of Life Scores
Description
Quality of life will be measured using the HerQLes quality of life questionnaire. HerQLes is a twelve-question instrument developed to evaluate quality of life and function as it pertains to the abdominal wall. It is converted into a 0-100 scale with 0 representing poor abdominal wall function, and 100 excellent function.
Time Frame
One Year Postoperatively

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: 18 years of age or older Will undergo a single-stage, open, retromuscular ventral hernia repair CDC Wound Class 1 Able to achieve midline fascial closure Hernia defect width less than or equal to 20 centimeters (measured intraoperatively) Able to tolerate general anesthesia Able to give informed consent Exclusion Criteria: Patients who are less than 18 years of age Patients who undergo emergent ventral hernia repair Patients who undergo laparoscopic or robotic ventral hernia repair Patients with CDC Wound Class 2, 3, or 4 Patients who are unable to undergo successful retromuscular mesh placement or who cannot achieve midline fascial closure Patients who undergo staged repair of their ventral hernia Patients who are unable to give informed consent Patients who cannot tolerate general anesthesia Patients who are pregnant at the time of surgical intervention
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michael J Rosen, MD
Organizational Affiliation
The Cleveland Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cleveland Clinic Foundation
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44195
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
IPD data will not be shared, rather the results of the aggregate groups of patients will be shared.
Citations:
PubMed Identifier
34524395
Citation
Krpata DM, Petro CC, Prabhu AS, Tastaldi L, Zolin S, Fafaj A, Rosenblatt S, Poulose BK, Pierce RA, Warren JA, Carbonell AM, Goldblatt MI, Stewart TG, Olson MA, Rosen MJ. Effect of Hernia Mesh Weights on Postoperative Patient-Related and Clinical Outcomes After Open Ventral Hernia Repair: A Randomized Clinical Trial. JAMA Surg. 2021 Dec 1;156(12):1085-1092. doi: 10.1001/jamasurg.2021.4309.
Results Reference
derived

Learn more about this trial

Heavy Weight Versus Medium Weight Mesh in Ventral Hernia Repair

We'll reach out to this number within 24 hrs